Igm Biosciencesincis A Biotechnology Company Based In Mountain Viewcaliforniathe Company Specializes In Developing Novel Antibody Based Therapeuticsfocusing On Immunoglobulin Migmantibodiesthese Antibodies Have Enhanced Binding Capabilitiesallowing Igm To Target Cancerautoimmune Diseasesand Inflammatory Conditions Effectively Igm Employs A Proprietary Antibody Engineering Platform To Create Therapies With Improved Target Engagement And Immune System Activationtheir Pipeline Includes Aplitabartan Igm Antibody For Colorectal Cancerand Imvotamaba Bispecific T Cell Engaging Antibody For Systemic Lupus Erythematosus And Rheumatoid Arthritisthe Company Is Also Advancing Multiple Preclinical Candidates Aimed At Autoimmune And Inflammatory Diseasesigm Is Dedicated To Addressing Unmet Medical Needs Through Innovative Antibody Engineering And Operates Primarily In The U Swith A Focus On Clinical Trials
